Report #2835006

Received Apr 9, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: NJ
Recovered: Unknown
Vaccinated: Jan 24, 2025
Onset: Jan 24, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEP	HEP B (HEPLISAV-B)	DYNAVAX TECHNOLOGIES CORPORATION	1	—	IM

Symptoms (1)

Incomplete course of vaccination

Symptom narrative

Had the first dose of Heplisav-B on 24JAN2025, and has not had the second dose yet; Initial report received on 19-Mar-2025. A consumer reported that she, a female (race, age, ethnicity not provided) received HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization but has not received the second dose yet. No medical history or concomitant vaccines were reported. On 24-Jan-2025, the patient received dose 1 of a hepatitis B vaccine [HEPLISAV-B (Lot #, expiration date, NDC #, route, and site not available). At the time of the report, 54 days after receiving dose 1 of HEPLISAV-B, the patient had not received the second dose yet. The reporter declined to provide further information. Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.